|

Diagnostic Accuracy of GPT-4o and Claude for HEART Score Calculation in Chest Pain

RECRUITINGSponsored by Marmara University Pendik Training and Research Hospital
Actively Recruiting
SponsorMarmara University Pendik Training and Research Hospital
Started2026-06
Est. completion2027-03
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This prospective observational diagnostic accuracy study evaluates whether large language models (LLMs) - GPT-4o (OpenAI, gpt-4o-2024-11-20) and Claude (Anthropic, claude-sonnet-4-6) - can accurately calculate HEART scores from unstructured Turkish clinical notes and predict 30-day major adverse cardiac events (MACE) in emergency department patients presenting with non-traumatic chest pain. The study will enroll 600 consecutive adult patients. For each patient, the same anonymized data (free-text anamnesis, ECG report text, troponin value, and age) will be independently processed by both LLMs via separate API calls with deterministic settings (temperature=0, JSON format). A three-expert consensus HEART score - derived through blinded independent scoring by three emergency medicine physicians with majority-vote adjudication - serves as the reference standard for agreement analysis. Actual 30-day MACE (all-cause death, AMI Type 1/2/4b, unplanned revascularization) determined via national health database and telephone follow-up serves as the outcome for diagnostic accuracy analysis. A secondary documentation-quality sub-study will quantify how spontaneously Turkish emergency anamnesis notes capture HEART score parameters.

Eligibility

Age: 18 Years+Healthy volunteers accepted
INCLUSION CRITERIA:

* Age \>=18 years
* Chief complaint of non-traumatic chest pain at the emergency department
* Written informed consent obtained from the patient or legally authorized representative
* Availability for 30-day follow-up (reachable by telephone and/or actively registered in the e-Nabiz national health database)

EXCLUSION CRITERIA:

* Traumatic chest pain etiology
* ST-elevation myocardial infarction (STEMI) at presentation requiring immediate reperfusion protocol
* Refusal or subsequent withdrawal of informed consent
* Inability to complete the mandatory 30-day follow-up period

WITHDRAWAL CRITERIA:

* Patient or representative requests data withdrawal after initial consent
* Administrative identification of retrospective data entry after enrollment

Conditions5

Artificial Intelligence (AI)Artificial Intelligence (AI) in DiagnosisChest Pain Rule Out Myocardial InfarctionEmergency MedicineHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.